İbrahim Çil

7PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - proteins and peptides (incl. medical proteomics)Cancer geneticsAboriginal and Torres Strait Islander health servicesEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 26, 2026
Revisiting Platinum Sensitivity in Relapsed Small-Cell Lung Cancer: Outcomes of Platinum-Containing Doublet Chemotherapy in the 3-6 Month Relapse Window.

|May 27, 2026
Prognostic Impact of Ectopic Fat Deposition Within the Psoas Muscle in Patients with Stage IV Pancreatic Cancer Receiving Systemic Chemotherapy.

|May 27, 2026
Risk Tier, Variant Certainty, and Real-World Care Patterns in Breast Cancer Patients with Germline Alterations in Breast Cancer Susceptibility Genes.

|Mar 27, 2026
Comparable Access, Different Outcomes: Breast Cancer Survival Among Syrian Refugees and Turkish Patients in Türkiye.

Ilker Nihat Ökten, Tuba Baydaş, Canan Karan

|Feb 17, 2022
The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study.

Muhammed Mustafa Atci, Baran Akagunduz, Metin Demir

|Aug 09, 2021
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study.

Ibrahim Cil, Ahmet Kucukarda, Muhammed Mustafa Atcı

Pageof 2

Frequent Collaborators

4 joint publications

Tuba Baydaş

4 joint publications

Ilker Nihat Ökten

3 joint publications

Baran Akagunduz

3 joint publications

Melike Ozcelik